Faculty
Edward B Lee, MD, PhD
Associate Professor of Pathology and Laboratory Medicine
Department: Pathology and Laboratory Medicine
Graduate Group Affiliations
Contact information
613A Stellar Chance Laboratories
422 Curie Blvd
Philadelphia, PA 19104
422 Curie Blvd
Philadelphia, PA 19104
Office: 215-898-0908
Lab: 215-662-6696
Lab: 215-662-6696
Education:
BS (Biological Sciences)
Stanford University, 1997.
PhD (Neuroscience)
University of Pennsylvania School of Medicine, 2004.
MD
University of Pennsylvania School of Medicine, 2005.
Permanent linkBS (Biological Sciences)
Stanford University, 1997.
PhD (Neuroscience)
University of Pennsylvania School of Medicine, 2004.
MD
University of Pennsylvania School of Medicine, 2005.
Description of Clinical Expertise
NeuropathologyDescription of Research Expertise
Alzheimer's diseaseFrontotemporal lobar degeneration
Amyotrophic lateral sclerosis
Selected Publications
Lee Edward B, Lee Virginia M-Y, Trojanowski John Q: Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Nature reviews. Neuroscience 13(1): 38-50, Nov 2011.Igaz Lionel M*, Kwong Linda K*, Lee Edward B*, Chen-Plotkin Alice, Swanson Eric, Unger Travis, Malunda Joe, Xu Yan, Winton Matthew J, Trojanowski John Q, Lee Virginia M-Y: Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice. The Journal of clinical investigation 121(2): 726-38, Feb 2011 Notes: *Lionel M Igaz, Linda K Kwong and Edward B Lee are co-lead authors.
Liu Elaine Y, Russ Jenny, Wu Kathryn, Neal Donald, Suh Eunran, McNally Anna G, Irwin David J, Van Deerlin Vivianna M, Lee Edward B: C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD. Acta neuropathologica 128(4): 525-41, Oct 2014.
Russ Jenny, Liu Elaine Y, Wu Kathryn, Neal Donald, Suh EunRan, Irwin David J, McMillan Corey T, Harms Matthew B, Cairns Nigel J, Wood Elisabeth M, Xie Sharon X, Elman Lauren, McCluskey Leo, Grossman Murray, Van Deerlin Vivianna M, Lee Edward B: Hypermethylation of repeat expanded C9orf72 is a clinical and molecular disease modifier. Acta neuropathologica 129(1): 39-52, Jan 2015.
McMillan Corey T, Russ Jenny, Wood Elisabeth M, Irwin David J, Grossman Murray, McCluskey Leo, Elman Lauren, Van Deerlin Vivanna, Lee Edward B: C9orf72 promoter hypermethylation is neuroprotective: Neuroimaging and neuropathologic evidence. Neurology 84(16): 1622-30, Apr 2015.
© The Trustees of the University of Pennsylvania | Site best viewed in a supported browser. | Site Design: PMACS Web Team.